Oops! Vivus awaits weight-loss drug approval, even as story breaks

Nothing stands in the way of a good FDA drug approval story -- except, of course, when the drug isn't yet approved.

USA Today ran a story online Tuesday about Mountain View-based Vivus Inc. (NASDAQ: VVUS) winning approval of its weight-loss drug, Qnexa. The story had new details about the drug -- like a new name (Qsymia) and when the drug would be available to consumers (later this year) -- as well as quotes attributed to President Peter Tam and a photo of Qsymia pills and bottles.

Great news, right? After all, the FDA was expected to rule on the drug Tuesday. Except the FDA has not -- at least, not yet -- approved Vivus' drug.